Flexeril Overdose (Cyclobenzaprine): Signs, Risks, and When to Seek Help

Edmund Murphy
Dr. David Miles
Written by Edmund Murphy on 27 September 2024
Medically reviewed by Dr. David Miles on 16 October 2024

Flexeril is the brand name of cyclobenzaprine, a muscle relaxant used to treat muscle spasms associated with short-term musculoskeletal conditions. Cyclobenzaprine overdose is unlikely to be fatal, although when combined with other substances, dangerous or lethal effects can occur. Signs of an overdose include shaking, agitation, changes in heart rate and blood pressure, and vomiting.

In the event of a Flexeril overdose or in case of an emergency, such as loss of consciousness or seizures, seek medical assistance immediately or call 911.

Key takeaways:
  • Symptoms of a Flexeril overdose include drowsiness, dizziness, nausea, shaking, slurred speech, and changes in blood pressure and heart rate.
  • Various substances interact with Flexeril, increasing the risk of overdose, particularly alcohol, opioids, and benzodiazepines.
  • People who abuse Flexeril may require professional treatment such as mental health care or substance use disorder treatment.
man wearing black feeling dizzy and confused due to Flexeril overdose

Can you overdose on Flexeril?

It is possible to overdose on muscle relaxers such as Flexeril when a higher dose than prescribed is taken, take other substances at the same time, or have an underlying condition. Flexeril (cyclobenzaprine) is a muscle relaxant used to treat muscle spasms and other musculoskeletal pain conditions.

A typical daily dose is up to 30 mg and anything above this can cause overdose, with symptoms including drowsiness, dizziness, nausea, vomiting, increased heart rate and blood pressure, and uncoordinated movements.

Can you die from Flexeril overdose?

According to reports and case studies, Flexeril overdoses cause little or no symptoms and are typically non-fatal. Even those who experience a serious Flexeril overdose are very likely to recover, following medical treatment and monitoring.

Although a Flexeril overdose is unlikely to be fatal, combining Flexeril with other substances, particularly other central nervous system (CNS) depressants, such as alcohol and opioids, can result in severe or lethal effects.

In rare cases, Flexeril overdose can be fatal. Factors that can increase the risk of death from Flexeril overdose include:

  • Combining Flexeril with other substances
  • Administering Flexeril to children or the elderly
  • Physical health conditions, particularly impaired liver functioning

A typical dose of cyclobenzaprine for an adult is up to 30 mg per day, split into three doses. It is not recommended to take more than this within 24 hours. High-risk groups should take smaller doses.

A potentially fatal dose of cyclobenzaprine may vary depending on the individual, their age, weight, and health. Any dose can cause overdose effects, although larger doses, particularly when combined with other substances, may be more likely to be dangerous or fatal.

Cyclobenzaprine overdose symptoms

Common signs of a cyclobenzaprine overdose include:

  • Drowsiness
  • Dizziness
  • Shaking
  • Agitation
  • Loss of coordination
  • Slurred speech
  • Nausea
  • Vomiting
  • Confusion
  • Increased heart rate and blood pressure

Potentially serious symptoms of cyclobenzaprine overdose are less common and often occur when abusing the drug alongside other substances. Serious symptoms may include:

  • Chest pain
  • Hallucinations
  • Severe drop in blood pressure
  • Severely reduced breathing
  • Trouble breathing
  • Irregular heartbeat
  • Heart failure
  • Seizures
  • Loss of consciousness
  • Neuroleptic malignant syndrome, a condition associated with unusual dopamine activity, causing symptoms such as muscle rigidity, difficulty swallowing, loss of consciousness, and high temperature.
  • Serotonin syndrome, a rare but potentially fatal condition caused by extremely high serotonin levels, resulting in symptoms such as fever, confusion, sweating, shaking, and twitching

What to do in case of a Flexeril overdose

If a Flexeril overdose is suspected, call Poison Control at 1-800-222-1222 for advice or contact a medical professional. If the person is unresponsive, cannot breathe, or is experiencing seizures, call 911 immediately.

In order to inform treatment, it can be helpful to ascertain which substances the individual has taken, in what doses, and at what time.

Treatment for Flexeril overdose

The individual may require hospital monitoring and treatment, including stomach pumping and activated charcoal to decontaminate the stomach.

Other symptoms may require monitoring and treatment, such as breathing difficulties, cardiac toxicity, or seizures.

Following overdose, the individual may be referred to specialist services, such as substance use disorder treatment or mental health professionals if a suicide attempt is suspected.

Flexeril drug interactions

Flexeril can enhance CNS depressant effects and increase the risk of respiratory depression and severe sedation. This includes:

  • Alcohol
  • Opioids
  • Benzodiazepines
  • Sleeping pills, tranquilizers, and sedatives
  • Anxiolytics

Flexeril is structurally similar to the tricyclic antidepressant amitriptyline and as such, there is a risk of serotonin syndrome occurring if combined with other serotonergic medications, particularly antidepressants such as:

Was this page helpful?

Your feedback allows us to continually improve our information

Resources:

  1. ALZA Corporation. (2001). Flexeril (Cyclobenzaprine Hydrochloride) Tablets. FDA. Retrieved from
  2. Linden, C.H., Mitchiner, J.C., Lindzon, R.D., & Rumack, B.H. (1983). Cyclobenzaprine Overdosage. Journal of Toxicology. Clinical Toxicology20(3), 281–288. Retrieved from
  3. Chabria, S.B. (2006). Rhabdomyolysis: A Manifestation of Cyclobenzaprine Toxicity. Journal of Occupational Medicine and Toxicology (London, England)1, 16. Retrieved from
  4. Winek, C.L., Jr, Wahba, W.W., & Winek, C.L. (1999). Drowning Due to Cyclobenzaprine and Ethanol. Forensic Science International100(1-2), 105–108. Retrieved from
  5. Spiller, H.A., & Cutino, L. (2003). Fatal Cyclobenzaprine Overdose with Postmortem Values. Journal of Forensic Sciences48(4), 883–884. Retrieved from
  6. National Institutes of Health. (Revised 2017). Cyclobenzaprine. Medline Plus. Retrieved from
  7. Mestres, J., Seifert, S.A., & Oprea, T.I. (2011). Linking Pharmacology to Clinical Reports: Cyclobenzaprine and its Possible Association with Serotonin Syndrome. Clinical Pharmacology and Therapeutics90(5), 662–665. Retrieved from
  8. Drugs.com. (Updated 2023). Cyclobenzaprine. Retrieved from
  9. Carrigan, C.G., & Lynch, D.J. (2003). Managing Suicide Attempts: Guidelines for the Primary Care Physician. Primary Care Companion to the Journal of Clinical Psychiatry5(4), 169–174. Retrieved from

Activity History - Last updated: 16 October 2024, Published date:


Reviewer

David is a seasoned Pharmacist, natural medicines expert, medical reviewer, and pastor. Earning his Doctorate from the Medical University of South Carolina, David received clinical training at several major hospital systems and has worked for various pharmacy chains over the years. His focus and passion has always been taking care of his patients by getting accurate information and thorough education to those who need it most. His motto: "Good Information = Good Outcomes".

Activity History - Medically Reviewed on 22 September 2024 and last checked on 16 October 2024

Medically reviewed by
Dr. David Miles

PharmD

Dr. David Miles

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (855) 648-7288
Helpline Information
Phone numbers listed within our directory for individual providers will connect directly to that provider.
Any calls to numbers marked with (I) symbols will be routed through a trusted partner, more details can be found by visiting https://recovered.org/terms.
For any specific questions please email us at info@recovered.org.

Related guides

Serotonin Syndrome

7 minutes read